MUC16 and ovarian cancer: Screening and monitoring of ovarian cancer typically focuses on detection of cancer antigen 125 (CA125) and use of the ovarian cancer risk algorithm (ROMA), but these methods are limited and have poor prognosis ability (5, 6).